Cargando…

Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility

The combination of Fe(3)O(4)@Ag superparamagnetic hybrid nanoparticles and nitric oxide (NO) represents an innovative strategy for a localized NO delivery with a simultaneous antibacterial and antitumoral actions. Here, we report the design of Fe(3)O(4)@Ag hybrid nanoparticles, coated with a modifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Pieretti, Joana Claudio, Gonçalves, Marcelly Chue, Nakazato, Gerson, Santos de Souza, Ana Carolina, Boudier, Ariane, Seabra, Amedea Barozzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936955/
https://www.ncbi.nlm.nih.gov/pubmed/33675446
http://dx.doi.org/10.1007/s10856-021-06494-x
_version_ 1783661294640955392
author Pieretti, Joana Claudio
Gonçalves, Marcelly Chue
Nakazato, Gerson
Santos de Souza, Ana Carolina
Boudier, Ariane
Seabra, Amedea Barozzi
author_facet Pieretti, Joana Claudio
Gonçalves, Marcelly Chue
Nakazato, Gerson
Santos de Souza, Ana Carolina
Boudier, Ariane
Seabra, Amedea Barozzi
author_sort Pieretti, Joana Claudio
collection PubMed
description The combination of Fe(3)O(4)@Ag superparamagnetic hybrid nanoparticles and nitric oxide (NO) represents an innovative strategy for a localized NO delivery with a simultaneous antibacterial and antitumoral actions. Here, we report the design of Fe(3)O(4)@Ag hybrid nanoparticles, coated with a modified and nitrosated chitosan polymer, able to release NO in a biological medium. After their synthesis, physicochemical characterization confirmed the obtention of small NO-functionalized superparamagnetic Fe(3)O(4)@Ag NPs. Antibacterial assays demonstrated enhanced effects compared to control. Bacteriostatic effect against Gram-positive strains and bactericidal effect against E. coli were demonstrated. Moreover, NO-functionalized Fe(3)O(4)@Ag NPs demonstrated improved ability to reduce cancer cells viability and less cytotoxicity against non-tumoral cells compared to Fe(3)O(4)@Ag NPs. These effects were associated to the ability of these NPs act simultaneous as cytotoxic (necrosis inductors) and cytostatic compounds inducing S-phase cell cycle arrest. NPs also demonstrated low hemolysis ratio (<10%) at ideal work range, evidencing their potential for biomedical applications. [Figure: see text]
format Online
Article
Text
id pubmed-7936955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-79369552021-04-05 Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility Pieretti, Joana Claudio Gonçalves, Marcelly Chue Nakazato, Gerson Santos de Souza, Ana Carolina Boudier, Ariane Seabra, Amedea Barozzi J Mater Sci Mater Med Delivery Systems The combination of Fe(3)O(4)@Ag superparamagnetic hybrid nanoparticles and nitric oxide (NO) represents an innovative strategy for a localized NO delivery with a simultaneous antibacterial and antitumoral actions. Here, we report the design of Fe(3)O(4)@Ag hybrid nanoparticles, coated with a modified and nitrosated chitosan polymer, able to release NO in a biological medium. After their synthesis, physicochemical characterization confirmed the obtention of small NO-functionalized superparamagnetic Fe(3)O(4)@Ag NPs. Antibacterial assays demonstrated enhanced effects compared to control. Bacteriostatic effect against Gram-positive strains and bactericidal effect against E. coli were demonstrated. Moreover, NO-functionalized Fe(3)O(4)@Ag NPs demonstrated improved ability to reduce cancer cells viability and less cytotoxicity against non-tumoral cells compared to Fe(3)O(4)@Ag NPs. These effects were associated to the ability of these NPs act simultaneous as cytotoxic (necrosis inductors) and cytostatic compounds inducing S-phase cell cycle arrest. NPs also demonstrated low hemolysis ratio (<10%) at ideal work range, evidencing their potential for biomedical applications. [Figure: see text] Springer US 2021-03-06 2021 /pmc/articles/PMC7936955/ /pubmed/33675446 http://dx.doi.org/10.1007/s10856-021-06494-x Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Delivery Systems
Pieretti, Joana Claudio
Gonçalves, Marcelly Chue
Nakazato, Gerson
Santos de Souza, Ana Carolina
Boudier, Ariane
Seabra, Amedea Barozzi
Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility
title Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility
title_full Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility
title_fullStr Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility
title_full_unstemmed Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility
title_short Multifunctional hybrid nanoplatform based on Fe(3)O(4)@Ag NPs for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility
title_sort multifunctional hybrid nanoplatform based on fe(3)o(4)@ag nps for nitric oxide delivery: development, characterization, therapeutic efficacy, and hemocompatibility
topic Delivery Systems
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936955/
https://www.ncbi.nlm.nih.gov/pubmed/33675446
http://dx.doi.org/10.1007/s10856-021-06494-x
work_keys_str_mv AT pierettijoanaclaudio multifunctionalhybridnanoplatformbasedonfe3o4agnpsfornitricoxidedeliverydevelopmentcharacterizationtherapeuticefficacyandhemocompatibility
AT goncalvesmarcellychue multifunctionalhybridnanoplatformbasedonfe3o4agnpsfornitricoxidedeliverydevelopmentcharacterizationtherapeuticefficacyandhemocompatibility
AT nakazatogerson multifunctionalhybridnanoplatformbasedonfe3o4agnpsfornitricoxidedeliverydevelopmentcharacterizationtherapeuticefficacyandhemocompatibility
AT santosdesouzaanacarolina multifunctionalhybridnanoplatformbasedonfe3o4agnpsfornitricoxidedeliverydevelopmentcharacterizationtherapeuticefficacyandhemocompatibility
AT boudierariane multifunctionalhybridnanoplatformbasedonfe3o4agnpsfornitricoxidedeliverydevelopmentcharacterizationtherapeuticefficacyandhemocompatibility
AT seabraamedeabarozzi multifunctionalhybridnanoplatformbasedonfe3o4agnpsfornitricoxidedeliverydevelopmentcharacterizationtherapeuticefficacyandhemocompatibility